This might be another milestone for the long way of developing AhR-directed therapeutic approaches for acute (e.g., SIRS/Sepsis) or chronic inflammatory diseases (e.g., chronic inflammatory bowel disease, rheumatoid arthritis, or allergies). This evidence concerns the gene AHR and allergic disease.